Publication
HHS delegates exclusion authority to CMS
HHS Secretary Robert F. Kennedy Jr. announced that the CMS would exercise exclusion authority to remove “bad actors” from federal healthcare programs “effective immediately.”
United States | Publication | August 2026
State-level scrutiny of private equity healthcare transactions is intensifying and an expanding web of state legislation now shapes the pace, structure, expense, and post-closing operational viability of healthcare transactions involving private equity. This article identifies key patterns, structures and practical impacts of certain current and pending state legislation that target private equity investment in the healthcare industry.
Most state laws in this space follow one of two models or some combination of them:
Similar to the premerger notification process under the Hart-Scott-Rodino Act, several states have adopted or are considering rules requiring notice to or approval of the AG or a designated state agency for certain healthcare transactions involving a change of ownership. To date, 13 states have enacted such statutes, including California, Connecticut, Illinois, Indiana, Maine, Massachusetts, Minnesota, Nevada, New Mexico, New York, Oregon, Rhode Island and Washington.1 Currently Indiana and Maine’s statutes require the most aggressive notice and review lead times.
Indiana’s law2 requires that written notice to the AG must be delivered at least 90 days prior to closing of any transaction between or involving two or more “health care entities,”3 whether by merger or acquisition4, where one entity holds assets of at least US$10 million in value. Once such notice is filed the AG has 45 days to review the notice and analyze any antitrust concerns with the transaction, and then either issue a civil investigative demand for additional information or allow the transaction to proceed by letting the 45-day review window expire with no further action. The AG is not obligated to respond to a notice and has discretion to investigate a transaction after this 45-day waiting period concludes.
Maine’s law5, effective January 1, 2027, requires 180-day prior written notice to and approval from the Maine Department of Health and Human Services (DHHS) for any “health care entity”6 pursuing a material change transaction7. Once a notice is filed, DHHS has 60 days to perform a preliminary review and approve the transaction without conditions, approve the transaction with conditions or refer the transaction for further comprehensive review. If DHHS requires further comprehensive review, such process may extend by over eight months, assuming prompt completion of requests for information by the underlying health care entity or parties to the transaction. Despite assignment of review and approval authority to DHHS, the AG and other state agencies also retain authority to enforce other applicable laws impacting the transaction, including antitrust laws, that may further impact and complicate a qualifying transaction.
Illinois currently requires certain healthcare facilities and provider organizations provide 30-day prior notice to the AG of any covered transaction8 between two or more healthcare facilities or provider organizations.9 If signed, Illinois House Bill 4728 (HB 4728) would add, among other things, an additional minimum 90-day notice requirement for intellectual and developmental disability service providers (IDD Providers) engaged in a transaction, which if consummated, would result in such service provider entity, its subsidiaries and affiliates or any contractual service providers under control or common control of such entity (Provider Group) being owned, managed or contained within a fund that is owned or managed by an asset management company10. Such minimum 90-day notice from IDD Providers would be submitted to the Illinois Health Facilities and Services Review Board (the Board). HB 4728 has passed both houses and is pending adoption by Governor Pritzker.
Accordingly, states like Indiana, Maine and Illinois regulate private equity involvement in the healthcare industry by targeting transactions likely to involve a private equity party. While this approach attempts to combine transparency for regulators with flexibility for the parties to finalize transaction details and implement post-closing operational arrangements, the practical impact is that the laws’ broad reach and extended time frames creates uncertainly for transaction parties based on the discretionary will of the AG or the designated state agency.
States such as Connecticut, Vermont, Oregon and Illinois have adopted or are considering rules directly targeting private equity groups or structures commonly utilized by private equity groups to participate in the healthcare industry.
Connecticut Senate Bill 196 was signed on May 27, 2026, and prohibits hospitals from entering into sale-leaseback agreements and requires hospitals to file annual attestations with the Connecticut Department of Public Health confirming that:
“(1) no private equity entity has a controlling interest in the hospital and that the entity holding the hospital’s license maintains full governance control and authority over the hospital’s assets and activities, including, but not limited to, all clinical, operational, managerial, financial and human resources matters, and (2) no private equity entity is permitted to influence a hospital’s adoption of any policy or procedure that would interfere with the professional judgment or clinical decisions of duly authorized clinicians, including (A) the amount of time spent with patients or the number of patients seen in a given time period, (B) the time permitted to triage patients in the emergency department or evaluate admitted patients, (C) the time period within which a patient must be discharged, (D) decisions involving a patient’s clinical status, including, but not limited to, whether the patient should be kept in observation status, whether the patient should receive palliative care and where the patient should be placed upon discharge, (E) the final diagnosis, diagnostic terminology or codes that are entered into the medical record, or (F) the appropriate diagnostic test for medical conditions.”
Connecticut Senate Bill 125 was signed on June 4, 2026, and requires nursing homes to provide the Commissioner of Social Services with the names of all investment entities11 with a beneficial ownership of five percent or more in the nursing home. On and after July 1, 2028, any nursing home that has a five percent or more beneficial ownership interest by an investment entity will be required to submit a surety bond in an amount equal to 90 days of operating costs to the Department of Public Health upon its subsequent renewal of its nursing home license.
Similarly, Vermont House Bill 583 (HB 583) was signed on June 15, 2026, and limits12 control over clinical decision making by private equity groups, hedge funds and entities they control (such as MSOs). HB 583 permits an unlicensed individual or entity from (i) providing nonclinical management, administrative or business services to, or (ii) assisting or consulting with, a healthcare facility doing business in Vermont, so long as a licensed healthcare provider retains the ultimate responsibility for or approval of those decisions and activities. Additionally, such provided services may not constitute an exercise of de facto control over the administrative, business or clinical operations of a healthcare facility in a manner that affects a healthcare provider’s clinical decision making or the nature or quality of the healthcare services that the healthcare facility delivers.
HB 583 also imposes several new ownership reporting requirements. On or before March 1, 2027, healthcare facilities and MSOs, in which one or more private equity groups or hedge funds held an ownership or investment interest as of June 1, 2026, must submit comprehensive ownership disclosures to the Green Mountain Care Board.13 Even if a healthcare facility or MSO has no prior or on-going association with a private equity group or hedge fund, such facility or MSO is nonetheless required to submit an attestation of such fact to the Green Mountain Care Board by March 1, 2027. After March 1, 2027, a comprehensive ownership disclosure will be required whenever a private equity group or hedge fund acquires an ownership or investment interest in a healthcare facility or MSO that had not previously reported to the Green Mountain Care Board or whenever there is a modification to a private equity group’s or hedge fund’s existing ownership or investment interest in a healthcare facility or MSO.
Likewise, if adopted by Illinois Governor Pritzker, HB 4728 will require IDD Providers that are owned, managed or contained within a fund owned or managed by an asset management company (Owned IDD Providers) to disclose significant information about their respective asset management company on a quarterly basis14. Additionally, Owned IDD Providers engaging in any transaction that would (i) sell, transfer, lease, exchange, option, encumber, convey or otherwise dispose of a material amount of the assets of a Provider Group, to one or more entities or (ii) transfer control, responsibility or governance of a material amount of the assets or operations of a Provider Group, to one or more entities, will be required to provide at least 90 days advance notice before entering into any such transaction, disclose the transaction along with copies of transaction agreements and documentation, and certify that such transaction, if consummated, will not cause a Provider Group, or the fund containing the same, to become financially distressed15.
MSOs and “friendly physician” structures are commonly utilized by private equity groups to participate in the healthcare industry in states that prohibit the corporate practice of medicine. States like Oregon that seek to specifically target and regulate private equity involvement in the healthcare industry have adopted or are considering statutes aimed directly at such structures.
Oregon Senate Bill 951 (SB 951) took effect on June 9, 2025, and broadly defines a management services organization as “an entity that under a written agreement, and in return for monetary compensation, provides management services to a professional medical entity” and targets three key areas of the “friendly physician” model:
Any agreement that violates these rules is void and unenforceable, and medical licensees or professional medical entities that suffer losses because of such violations may bring legal action against an MSO.
Targeted regulation like SB 951 impose restrictions and unique obligations on healthcare providers associated with private equity to more closely oversee the involvement of private equity. States utilizing this approach seek to establish guardrails around private equity ownership and address certain concerns related to private equity involvement in the healthcare industry. While restrictive in several ways, this approach may establish clear operational pathways that are not burdened by uncertain discretionary approval for pending transactions.
Parties involved in healthcare private equity transactions must actively monitor legislative developments and carefully navigate an increasingly complicated and restrictive web of state regulations, in addition to existing and evolving federal regulations, including the following 2026 pending legislative efforts and developments under consideration:
Introduced on January 27, 2026, Senate Bill 41 would require parties to a merger, acquisition or contracting affiliation of one or more healthcare entities to comply with specified notice requirements at least 60 days before the closing of a material change transaction.
Introduced on January 28, 2026, Senate Bill 3175 would require certain healthcare entities to provide notice of material healthcare transactions 180 days prior to closing.
Sent to Governor Pritzker’s desk following legislative approval, House Bill 5000, if signed, would expand the current scope of “covered transactions” to include transactions involving entities that directly or indirectly own or control healthcare entities, which would include private equity companies.
Senate Bill 219 would incorporate into Indiana’s law governing businesses and other associations the Uniform Antitrust Pre-Merger Notification Act, as approved and recommended for enactment in all states by the Uniform Law Commission.
Senate File 2236 would prohibit the Department of Inspections, Appeals and Licensing from approving any change of ownership of a nursing facility if the person seeking to obtain ownership is owned in majority by, or is an affiliate of, a private equity fund or real estate investment trust.
Despite being introduced on March 24, 2025, House Bill 2779 (HB 2779) received two additional sponsors as of February 17, 2026. HB 2779 would require healthcare entities to report information concerning their ownership or control to the commissioner of health, would require annual public reports be submitted by healthcare entities and would grant authority to the commissioner of health to audit and inspect records of healthcare entities as well as assess civil penalties.
Introduced on February 4, 2026, Senate Bill 666/LSR 2026-3268 would require notice to the department of justice of healthcare transactions that change control of a healthcare entity and that may reasonably be expected to affect competition, cost of healthcare services or access to care as well as would authorize said department to review, monitor and approve such transactions and enforce violations.
House Bill 2115 would require certain healthcare entities to provide notice to the AG of healthcare transactions that result in a change of ownership 120 days prior to closing.
Several bills16 were introduced in 2026 that as currently drafted would require significant disclosures for material changes of covered care entities involving private equity companies, would require certain healthcare entities to provide notice to the AG and the department of health of any material change transaction 180 days prior to closing and would codify the corporate practice of medicine doctrine.
Norton Rose Fulbright continues to monitor these legislative developments and is available to assist clients and other interested parties with navigating them. As the pace and breadth of state-level legislative activity continues to accelerate, early engagement with experienced counsel is critical to identifying applicable requirements, structuring compliant transactions and mitigating regulatory risk. If you have any questions or require assistance, please contact the authors listed below.
Cal. Health & Saf. Code § 127500 et seq., Conn. Gen. Stat. § 19a-486i, 740 Ill. Comp. Stat. 10/7.2a, IC §§ 25-1-8.5-1 — 25-1-8.5-4, Maine statutes to be codified at 22 MRSA ch. 106, §§ 371–373 , Mass. Gen. Laws Ch. 6D § 13, Minn. Stat. §§ 145D.01-0.2, Nev. Rev. Stat. § 598A.290 et seq., Nev. Rev. Stat. § 439A.126, NMSA 24A-9-1, N.Y. Pub. Health Law § 4550 et seq., Or. Rev. Stat. § 415.500 et seq., 110-RICR-30-00-5, and Wash. Rev. Code § 19.390.
“Financially distressed” means any time at which an entity subject to HB 4728: (1) fails to timely meet payroll obligations for a period of more than 90 days; (2) initiates dissolution or close; (3) is behind on rent payments for a period of more than 90 days; (4) has defaulted on a loan for a period of more than 90 days; (5) is the subject of either (i) an order for relief under Title 11 of the United States Code on behalf of the facility, its subsidiaries, its affiliates, its parent companies, or contractual service providers under control of the entity, its subsidiaries, its affiliates, or its parent companies or (ii) the commencement of any other insolvency proceeding; (6) has their ratio of total liabilities to earnings before interest, taxes, depreciation, and amortization (EBITDA) either: (A) increase over four consecutive quarters to a debt-to-EBITDA ratio greater than four; or (B) experience an increase over three consecutive quarters if its initial debt-to-EBITDA ratio was greater than four.
House Bill 7172, House Bill 7720, House Bill 7721, Senate Bill 2459, and Senate Bill 2492.
Publication
HHS Secretary Robert F. Kennedy Jr. announced that the CMS would exercise exclusion authority to remove “bad actors” from federal healthcare programs “effective immediately.”
Publication
Now in its seventh year, our annual English Premier League (EPL) football report, Keeping Possession, captures insights from our global sports law team on the key trends and topics shaping the landscape of English football.
Subscribe and stay up to date with the latest legal news, information and events . . .
© Norton Rose Fulbright LLP 2026